Latham & Watkins LLP represented Traeger, while Fried Frank acted as counsel to Morgan Stanley & Co. LLC, as representative of the underwriters, in the IPO....
Traeger’s $487 Million Initial Public Offering
Absci Corporation’s $200 Million Initial Public Offering
Goodwin Procter advised Absci, while Latham & Watkins represented the underwriters in the offering. Absci Corporation (Absci), the synthetic biology company unlocking the potential of proteins...
Lyell Immunopharma’s $425 Million Initial Pubic Offering
Latham & Watkins Advises the Underwriters in the offering while Cooley LLP represented Lyell Immunopharma. Lyell Immunopharma, Inc. (Lyell), (Nasdaq: LYEL), a T cell reprogramming company...
Switch’s $420 Million Acquisition of Data Foundry
Latham & Watkins LLP represented Switch in the transaction. Switch, Inc. (NYSE: SWCH), the exascale technology infrastructure corporation, has entered into a definitive agreement to acquire Data Foundry,...
Roivant Sciences Ltd.’s Merger with Montes Archimedes Acquisition Corp.
Conyers and Davis Polk & Wardwell is advising Roivant Sciences Ltd., in its business combination by merger of a subsidiary with Montes Archimedes Acquisition Corp. (MAAC)...
Green Plains’ Common Stock and Convertible Senior Notes Offerings
Latham & Watkins LLP represented the underwriters in the offerings. Green Plains Inc., a leading biorefining company, has announced the pricings of its underwritten public offerings...